Potential antigenic explanation for atypical h1n1 infections among middle-aged adults during the 2013-2014 influenza season

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 44, 2014, Pages 15798-15803

  Linderman, Susanne L ^a,b   Chambers, Benjamin S ^a,b   Zost, Seth J ^a,b   Parkhousea, Kaela ^a   Li, Yang ^a,b   Herrmann, Christin ^a,b   Ellebedy, Ali H ^c,d   Carter, Donald M ^e   Andrews, Sarah F ^e   Zheng, Nai Ying ^e   Huang, Min ^e   Huang, Yunping ^e   Strauss, Donna ^f   Shaz, Beth H ^f   Hodinka, Richard L ^g,h   Reyes Terán, Gustavo ⁱ   Ross, Ted M ^e   Wilson, Patrick C ^e   Ahmed, Rafi ^c,d   Bloom, Jesse D ^j   Hensley, Scott E ^a,b   more..

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Vaccine and Gene Therapy Institute of Florida   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h NEW YORK BLOOD CENTER   (United States)

ⁱ INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^j Fred Hutchinson Cancer Research Center   (United States)

more..

Author keywords

Antibody; Antigenic drift; Hemagglutinin; Influenza; Vaccine

Indexed keywords

EPITOPE; HEMAGGLUTININ; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIGEN;

ADAPTIVE IMMUNITY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; FERRET; GENE MUTATION; GLYCOSYLATION; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA A (H1N1); MIDDLE AGED; MOUSE; NONHUMAN; REVERSE GENETICS; SEASONAL INFLUENZA; VACCINATION; VIRUS GENE; VIRUS STRAIN; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CLINICAL TRIAL; FEMALE; GENETICS; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); MALE; MORTALITY; MUTATION; PATHOGENICITY;

ORTHOMYXOVIRIDAE;

ADULT; ANIMALS; ANTIGENS, VIRAL; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; MUTATION;

EID: 84914695546     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1409171111     Document Type: Article

References (33)

1. Dawood FS, et al.; Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360(25):2605-2615.
2. Smith GJ, et al. (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459(7250):1122-1125.
3. Garten RJ, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325(5937):197-201.
4. Manicassamy B, et al. (2010) Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 6(1):e1000745.
5. Skountzou I, et al. (2010) Immunity to pre-1950 H1N1 influenza viruses confers crossprotection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 185(3):1642-1649.
6. Xu R, et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328(5976):357-360.
7. Jacobs JH, et al. (2012) Searching for sharp drops in the incidence of pandemic A/H1N1 influenza by single year of age. PLoS ONE 7(8):e42328.
8. Mertz D, et al. (2013) Populations at risk for severe or complicated influenza illness: Systematic review and meta-analysis. BMJ 347:f5061.
9. Arriola CS, et al.; Centers for Disease Control and Prevention (CDC) (2014) Update: Influenza activity-United States, September 29, 2013-February 8, 2014. MMWR Morb Mortal Wkly Rep 63(7):148-154.
10. Ayscue P, et al.; Centers for Disease Control and Prevention (CDC) (2014) Influenzaassociated intensive-care unit admissions and deaths-California, September 29, 2013-January 18, 2014. MMWR Morb Mortal Wkly Rep 63(7):143-147.
11. Dávila J, et al. (2014) Substantial morbidity and mortality associated with pandemic A/ H1N1 influenza in Mexico, winter 2013-2014: Gradual age shift and severity. PLoS Curr 6:6.
12. Epperson S, et al.; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC (2014) Influenza activity-United States, 2013-14 season and composition of the 2014 - 15 influenza vaccines. MMWR Morb Mortal Wkly Rep 63(22):483-490.
13. Stöhr K, Bucher D, Colgate T, Wood J (2012) Influenza virus surveillance, vaccine strain selection, and manufacture. Methods Mol Biol 865:147-162.
14. Li Y, et al. (2013) Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med 210(8):1493-1500.
15. Chen Z, et al. (2010) Generation of live attenuated novel influenza virus A/California/ 7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 84(1):44-51.
16. Miller MS, et al. (2013) Neutralizing antibodies against previously encountered influenza virus strains increase over time: A longitudinal analysis. Sci Transl Med 5(198): 198ra107.
17. Davenport FM, Hennessy AV, Francis T, Jr (1953) Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med 98(6):641-656.
18. Webster RG (1966) Original antigenic sin in ferrets: The response to sequential infections with influenza viruses. J Immunol 97(2):177-183.
19. Virelizier JL, Postlethwaite R, Schild GC, Allison AC (1974) Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med 140(6):1559-1570.
20. Virelizier JL, Allison AC, Schild GC (1974) Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: A bone marrowderived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med 140(6):1571-1578.
21. Kim JH, Skountzou I, Compans R, Jacob J (2009) Original antigenic sin responses to influenza viruses. J Immunol 183(5):3294-3301.
22. De St Groth F, Webster RG (1966) Disquisitions on original antigenic sin. II. Proof in lower creatures. J Exp Med 124(3):347-361.
23. Li GM, et al. (2012) Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci USA 109(23):9047-9052.
24. Wrammert J, et al. (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 208(1): 181-193.
25. Carter DM, et al. (2013) Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. J Virol 87(3):1400-1410.
26. Pica N, et al. (2012) Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci USA 109(7):2573-2578.
27. Catania J, Que LG, Govert JA, Hollingsworth JW, Wolfe CR (2014) High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination. Am J Respir Crit Care Med 189(4):485-487.
28. Caton AJ, Brownlee GG, Yewdell JW, GerhardW (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31(2 Pt 1):417-427.
29. De St Groth F, Webster RG (1966) Disquisitions of original antigenic sin. I. Evidence in man. J Exp Med 124(3):331-345.
30. Krause JC, et al. (2011) Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence. J Immunol 187(7):3704-3711.
31. Smith DJ, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305(5682):371-376.
32. Koel BF, et al. (2013) Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342(6161):976-979.
33. th Ed.